| Dr Joseph C Eshelman, MD | |
|
5500 S Marginal Rd, Cleveland, OH 44103-1072 | |
| (216) 426-9020 | |
| Not Available |
| Full Name | Dr Joseph C Eshelman |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Occupational Medicine |
| Location | 5500 S Marginal Rd, Cleveland, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033309414 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083X0100X | Preventive Medicine - Occupational Medicine | 35054803 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph C Eshelman, MD 9456 Greystone Pkwy, Brecksville, OH 44141-2941 Ph: (216) 905-0921 | Dr Joseph C Eshelman, MD 5500 S Marginal Rd, Cleveland, OH 44103-1072 Ph: (216) 426-9020 |
News Archive
A novel nasal treatment developed to boost the natural human immune system to fight common colds and flu, has proved remarkably successful in reducing COVID-19 viral replication test results, released today, reveal.
Boys are twice as likely as girls in the U.S. and Asia (mostly Japan) to receive recombinant human growth hormone (rhGH) for growth hormone deficiency, illnesses that affect height, and short stature of a non-medical nature.
Among older adults with a recent heart attack, those with lower levels of kidney function are less likely to take their medications as prescribed, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology.
Today is World Psoriasis Day and the National Psoriasis Foundation is asking all Americans affected by psoriasis and psoriatic arthritis to raise awareness about these diseases by going to www.psoriasis.org/wpd and taking action.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a biological therapy with a mechanism of action other than tumor necrosis factor alpha (TNF-alpha) inhibition for the treatment of moderate to severe ulcerative colitis, would earn a 25 percent patient share according to surveyed U.S. gastroenterologists. Similarly, in Europe, such an agent would also earn 25 percent patient share according to surveyed European gastroenterologists.
› Verified 5 days ago
Francis J Yuhas, D.O. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 4660 Hinckley Industrial Pkwy, Cleveland, OH 44109 Phone: 615-778-4066 | |
Irina Arkhipova-jenkins, M.D. Preventive Medicine Medicare: Medicare Enrolled Practice Location: Bariatric And Metabolic Institute 9500 Euclid Ave, Cleveland, OH 44195 Phone: 216-444-2200 | |
Patrick G Bray, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 2522 E 22nd St, Svch Occupational Medicine, Cleveland, OH 44115 Phone: 216-363-2691 Fax: 216-694-4665 | |
Dr. Zenobia K Tayeb, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 9500 Euclid Ave # Q2-1, Cleveland, OH 44195 Phone: 216-448-4325 | |
Kathleen M Fagan, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 11100 Euclid Avenue, Cleveland, OH 44106 Phone: 216-844-7700 Fax: 216-286-6299 | |
Scott E Singer, MD MPH Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 8555 Sweet Valley Dr, Cleveland, OH 44125 Phone: 216-328-2240 Fax: 216-642-7945 |